These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34432895)

  • 1. Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease.
    Shui X; Wen Z; Chen Z; Xie X; Wu Y; Zheng B; Wu Z; Chen L
    Clin Cardiol; 2021 Nov; 44(11):1551-1559. PubMed ID: 34432895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.
    Leistner DM; Laguna-Fernandez A; Haghikia A; Abdelwahed YS; Schatz AS; Erbay A; Roehle R; Fonseca AF; Ferber P; Landmesser U
    Eur J Prev Cardiol; 2024 May; 31(7):856-865. PubMed ID: 38348689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
    Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study.
    Liu SL; Wu NQ; Guo YL; Zhu CG; Gao Y; Sun J; Xu RX; Liu G; Dong Q; Li JJ
    Postgrad Med J; 2019 Oct; 95(1128):534-540. PubMed ID: 31315919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) Is Associated with the Presence and Severity of New-Onset Coronary Artery Disease in Postmenopausal Women.
    Yan XN; Jin JL; Hong LF; Guo YL; Wu NQ; Zhu CG; Dong Q; Li JJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):503-510. PubMed ID: 31905317
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study.
    Zhou BY; Sun D; Wang C; Wu NQ; Guo YL; Zhu CG; Gao Y; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2019 Jul; 28(7):1009-1017. PubMed ID: 31178022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
    Lin LH; Liu H; Tu Y; Yang Y; Wang B; Wang FM; Wu M; Pan MM; Tang RN; Ma KL; Zhang XL; Liu BC
    Coron Artery Dis; 2019 Mar; 30(2):137-142. PubMed ID: 30585793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.
    Loh WJ; Chang X; Aw TC; Phua SK; Low AF; Chan MY; Watts GF; Heng CK
    Atherosclerosis; 2022 May; 349():160-165. PubMed ID: 34887076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
    Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
    Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease.
    Patel RS; Su S; Neeland IJ; Ahuja A; Veledar E; Zhao J; Helgadottir A; Holm H; Gulcher JR; Stefansson K; Waddy S; Vaccarino V; Zafari AM; Quyyumi AA
    Eur Heart J; 2010 Dec; 31(24):3017-23. PubMed ID: 20729229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patients.
    Shi YP; Cao YX; Jin JL; Liu HH; Zhang HW; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Coron Artery Dis; 2021 Jan; 32(1):78-83. PubMed ID: 32804783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lipoprotein(a) with coronary severity in patients with new-onset acute myocardial infarction: A large cross-sectional study.
    Wang Z; Xiao S; Liu N
    Clin Chim Acta; 2023 Feb; 540():117220. PubMed ID: 36621598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease.
    Shui X; Wen Z; Dong R; Chen Z; Tang L; Tang W; Wu Z; Chen L
    Lipids Health Dis; 2023 Aug; 22(1):125. PubMed ID: 37559117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women.
    Sposito AC; Mansur AP; Maranhão RC; Martinez TR; Aldrighi JM; Ramires JA
    Maturitas; 2001 Sep; 39(3):203-8. PubMed ID: 11574179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.